• ATyr slashes headcount, cuts costs after ORCA runs aground fiercebiotech
    May 16, 2018
    ATyr Pharma is laying off 30% of its staff and otherwise cutting its costs in response to lackluster data. The biotech made the cuts after preclinical data on its anticancer antibodies suggested they lack the required efficacy.
PharmaSources Customer Service